Cold-chain logistics platform for cell therapy, clinical trials, and organ transport
Mercury operates a 40-year-old cold-chain logistics business serving biotech and life-sciences companies, now modernizing its core operations. The tech stack (Java, PostgreSQL, Docker, GitHub Actions) and active projects (next-generation shipment platform, API layer, test automation) signal a shift from legacy logistics infrastructure toward a software-first, platform-based model. Engineering hiring (6 roles, mostly senior and manager-level) heavily outweighs sales (1 role), indicating the company is investing in product and reliability rather than expanding market reach — a deliberate choice for a 51–200-person operation serving highly regulated, high-stakes customers.
Mercury moves time- and temperature-critical materials for biotech, diagnostics, and medical-device companies across 160+ countries. The service portfolio spans cell and gene-therapy materials, clinical-trial drugs, biological samples, organs and tissue, and medical devices — all shipped under GDP compliance and validated for extreme temperature ranges (-196°C to +25°C). The business model combines 24/7 customer squads (named logistics experts), a real-time shipment portal with GPS and temperature tracking, and specialized capabilities like on-board courier and direct-to-patient delivery. Headquarters in Boston, MA; privately held since 1984.
Java, PostgreSQL, Docker, GitHub, GitHub Actions, TypeScript, Playwright, REST Assured, HubSpot, and Salesforce. The stack reflects a modernized approach to logistics software with containerized deployment and automated testing.
Boston, MA. The company was founded in 1984 and is privately held with 51–200 employees.
Other companies in the same industry, closest in size